Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants

Clinical trial NCT00775632 · COMPLETED

Trial details

NCT number: NCT00775632
Sponsor: University Health Network, Toronto
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft Versus Host Disease Bone Marrow Transplantation

Start date: 2008-10-01
Primary completion: 2010-09-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.